Within the PI3K/AKT/mTOR pathway, we identified ten genes that are differentially expressed in the blood samples of LM patients, including ribosomal protein S6 kinase B2 (RPS6KB2) and cyclin D3 (CCND3) (Fig 3B). Here, AKT1 is linked to lymphangioma.